CapsoVision, Inc. CV | NASDAQ
|2026-11-05
Company Overview:
1.4 Year CV Performance Metrics:
Build Custom Charts
CV Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
Projected Future Returns & Dividends for CV
Based on past 1.4-year performance, here are CV growth metrics:
Share price CAGR of +48.88%
Dividend CAGR of +0%
Using CV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| CV (DRIP) | CV - No DRIP | |
|---|---|---|
| Current Price | $6.11 | $6.11 |
| Start Shares | 1,636.66 | 1,636.66 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 1,636.66 | 1,636.66 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $6.11 | $6.11 |
| Total Dividends | $0 | $0 |
| Final Value | $10,000 | $10,000 |
NOTE: Above numbers are our estimate based on CV's Dividend and Price CAGR over past 1.4 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Company Info
CapsoVision, Inc. (CV) had its IPO on 2025-07-02, and is traded on NASDAQ stock exchange.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
CV website: https://capsovision.com
DCF Model — CV
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
| Year | FCF | Implied price |
|---|
